23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › IDEAYA BIOSCIENCES INC. › 2023-2024

IDEAYA BIOSCIENCES INC. 2023-2024 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and IDEAYA BIOSCIENCES INC.’s Form 8-K, filed May 31, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 5Reported items
  • 239Asset managers, any item
  • 1,798Fund votes
  • May 31, 2024Meeting date

Results at a glance

Meeting of May 31, 2024: 4 items on IDEAYA BIOSCIENCES INC.’s Form 8-K, filed May 31, 2024: 4 passed (calculated).

Dissent

Significant dissent: 1 director (21.2% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore IDEAYA BIOSCIENCES INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by IDEAYA BIOSCIENCES INC.

These tallies are IDEAYA BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 31, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

IDEAYA BIOSCIENCES INC. — official shareholder meeting results, meeting held May 31, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Terry J. Rosen, Ph.D. 54,533,987---- 14,635,1871,769,710 79%Passed (calculated)—
Elect Director: Wendy L. Yarno 64,201,258---- 4,521,7622,215,864 93%Passed (calculated)—
2. The ratification of the selection, by the Audit Committee of the Board of Directors of the Company, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2024 70,923,1756,2959,414 ---- 99.9%Passed (calculated)—
3. Non-binding, advisory vote to approve the compensation of the Company's named executive officers 62,946,6924,602,3381,646,579 --1,743,275 93%Passed (calculated)—

Source: IDEAYA BIOSCIENCES INC., Form 8-K, filed with the SEC on May 31, 2024 — read the filing on EDGAR.

How asset managers voted at the IDEAYA BIOSCIENCES INC. 2023-2024 meeting

239 asset managers disclosed a vote on at least one IDEAYA BIOSCIENCES INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of IDEAYA BIOSCIENCES INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

Elect Director: Wendy L. Yarno

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 5 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 64,201,258WITHHELD: 4,521,762
Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: To elect two Class II directors to hold office until the 2027 annual meeting of stockholders or until their successors are elected: Wendy L. Yarno

IDEAYA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Wendy L. Yarno”): 64,201,258 for, 4,521,762 withheld, per its Form 8-K filed May 31, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 28,994,219 for, 2,803,202 withheld.

FOR
FOR: 28,994,219WITHHOLD: 2,803,202
Largest asset managers voting on “To elect two Class II directors to hold office until the 2027 annual meeting of stockholders or until their su” at IDEAYA BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity7,419,0050 00For
Federated Hermes4,855,7900 00For
Vanguard4,019,9690 00For
T. Rowe Price3,122,9830 00For
JANUS INVESTMENT FUND2,071,4380 00For
Capital Group1,976,8700 00For
BlackRock1,973,7630 00For
State Street39,1990 01,612,502Withhold
Dimensional00 01,095,679Withhold
Charles Schwab570,3070 00For
MUTUAL FUND SERIES TRUST335,0000 00For
TIAA293,7650 00For
Victory Capital236,2790 00For
Prudential/PGIM203,1850 00For
Equitable191,3070 00For
Invesco175,5330 00For
Columbia Threadneedle120,3540 00For
Bridge Builder Trust107,9050 00For
New York Life104,7830 00For
Direxion Shares ETF Trust98,7850 00For
Lincoln Financial24,3970 057,862Mixed
First Trust80,5100 00For
Northern Trust68,6340 00For
Goldman Sachs65,9990 00For
Nushares ETF Trust63,9990 00For

Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).

Elect Director: Terry J. Rosen, Ph.D.

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 5 wordings of this item as funds reported it.

79% Majority: yes · of votes cast

FOR 79%WITHHELD
FOR: 54,533,987WITHHELD: 14,635,187
Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: To elect two Class II directors to hold office until the 2027 annual meeting of stockholders or until their successors are elected: Terry J. Rosen, Ph.D.

IDEAYA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Terry J. Rosen, Ph.D.”): 54,533,987 for, 14,635,187 withheld, per its Form 8-K filed May 31, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 28,631,468 for, 45 against, 3,165,908 withheld.

FOR
FOR: 28,631,468AGAINST: 45WITHHOLD: 3,165,908
Largest asset managers voting on “To elect two Class II directors to hold office until the 2027 annual meeting of stockholders or until their su” at IDEAYA BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity7,415,1050 03,900For
Federated Hermes4,855,7900 00For
Vanguard4,013,4690 06,500For
T. Rowe Price3,122,9830 00For
JANUS INVESTMENT FUND1,351,7240 0719,714Mixed
Capital Group1,976,8700 00For
BlackRock1,973,7630 00For
State Street1,628,1650 023,536For
Dimensional00 01,095,679Withhold
Charles Schwab570,3070 00For
MUTUAL FUND SERIES TRUST335,0000 00For
TIAA293,7650 00For
Victory Capital00 0236,279Withhold
Prudential/PGIM172,4250 030,760Mixed
Equitable125,9070 065,400Mixed
Invesco00 0175,533Withhold
Columbia Threadneedle120,3540 00For
Bridge Builder Trust17,3940 090,511Mixed
New York Life104,7830 00For
Direxion Shares ETF Trust00 098,785Withhold
Lincoln Financial53,7000 028,559Mixed
First Trust00 080,510Withhold
Northern Trust68,6340 00For
Goldman Sachs00 065,999Withhold
Nushares ETF Trust63,9990 00For

Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).

Non-binding, advisory vote to approve the compensation of the Company's named executive officers

Calculated outcomeFund totals may overlapSECTION 14A SAY-ON-PAY VOTESPassed (calculated)

Combines 14 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 62,946,692AGAINST: 4,602,338
Details: description as filed, official tally, votes by 238 asset managers

Description as filed by funds: To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders;

IDEAYA BIOSCIENCES INC.’s own tally for this item (“3. The non-binding, advisory vote to approve the compensation of the Company's named executive officers”): 62,946,692 for, 4,602,338 against, per its Form 8-K filed May 31, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 74 asset managers voting on “To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as di” at IDEAYA BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity7,419,0050 00For
Federated Hermes4,855,7900 00For
Vanguard4,019,9690 00For
T. Rowe Price3,122,9830 00For
JANUS INVESTMENT FUND2,071,4380 00For
Capital Group01,976,870 00Against
BlackRock1,973,7630 00For
State Street1,651,7010 00For
Dimensional1,095,6790 00For
Charles Schwab570,3070 00For
MUTUAL FUND SERIES TRUST335,0000 00For
TIAA293,7650 00For
Victory Capital236,2790 00For
Prudential/PGIM174,39428,791 00Mixed
Equitable191,3070 00For
Invesco175,5330 00For
Columbia Threadneedle120,3540 00For
Bridge Builder Trust107,9050 00For
New York Life104,7830 00For
Direxion Shares ETF Trust98,7850 00For
Lincoln Financial82,2590 00For
First Trust80,5100 00For
Northern Trust68,6340 00For
Goldman Sachs65,9990 00For
Nushares ETF Trust63,9990 00For

Fund voting reports, all 74 managers: 29,757,265 for, 2,033,790 against, 6,828 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 189 asset managers voting on “To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as di” at IDEAYA BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
New York Life19,000,0000 00For
Fidelity10,202,4800 00For
Federated Hermes4,855,9970 00For
T. Rowe Price3,912,3230 00For
Janus Henderson3,774,3640 00For
State Street2,926,4730 00For
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)2,494,5530 00For
ADAGE CAPITAL PARTNERS GP, L.L.C.2,415,7070 00For
Boxer Capital, LLC2,202,8120 00For
Capital Research Global Investors01,976,870 00Against
BlackRock1,754,7390 00For
Logos Global Management LP1,550,0000 00For
GEODE CAPITAL MANAGEMENT, LLC1,415,1490 00For
BVF INC/IL1,157,8060 00For
PICTET ASSET MANAGEMENT SA1,152,4850 00For
Fiera Capital Corp982,0700 00For
Holocene Advisors, LP911,0540 00For
Redmile Group, LLC891,5510 00For
Candriam S.C.A.630,0000 00For
Charles Schwab570,3070 00For
BOONE CAPITAL MANAGEMENT LLC531,9670 00For
Citadel526,0570 00For
DAFNA Capital Management LLC446,3410 00For
Woodline Partners LP426,1160 00For
Victory Capital387,9400 00For

No total is shown for the institutional-manager reports: their sum exceeds the company's reported shares outstanding. Showing the 25 largest; every one is in the interactive database (link above).

To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensation of…

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTESSECTION 14A SAY-ON-PAY VOTES

Combines 8 wordings of this item as funds reported it.

100% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: description as filed, votes by 227 asset managers

Description as filed by funds: To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensation of the Company's named executive officers; and

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 74 asset managers voting on “To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensat” at IDEAYA BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity00 00--
Federated Hermes00 00--
Vanguard00 00--
T. Rowe Price00 00--
JANUS INVESTMENT FUND00 00--
Capital Group00 00--
BlackRock00 00--
State Street00 00--
Dimensional00 00--
Charles Schwab00 00--
MUTUAL FUND SERIES TRUST335,0000 00For
TIAA00 00--
Victory Capital00 00--
Prudential/PGIM00 00--
Equitable00 00--
Invesco00 00--
Columbia Threadneedle00 00--
Bridge Builder Trust00 00--
New York Life00 00--
Direxion Shares ETF Trust00 00--
Lincoln Financial00 00--
First Trust00 00--
Northern Trust00 00--
Goldman Sachs00 00--
Nushares ETF Trust00 00--

Fund voting reports, all 74 managers: 335,507 for, 6,828 abstained, 30,329,737 1 year, 1,125,811 3 year. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 178 asset managers voting on “To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensat” at IDEAYA BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
New York Life00 00--
Fidelity00 00--
Federated Hermes00 00--
T. Rowe Price00 00--
Janus Henderson00 00--
State Street00 00--
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)00 00--
Boxer Capital, LLC00 00--
Capital Research Global Investors00 00--
BlackRock00 00--
Logos Global Management LP00 00--
GEODE CAPITAL MANAGEMENT, LLC00 00--
BVF INC/IL00 00--
PICTET ASSET MANAGEMENT SA00 00--
Fiera Capital Corp00 00--
Holocene Advisors, LP00 00--
Redmile Group, LLC00 00--
Candriam S.C.A.00 00--
Charles Schwab00 00--
BOONE CAPITAL MANAGEMENT LLC00 00--
Citadel00 00--
DAFNA Capital Management LLC00 00--
Woodline Partners LP00 00--
Victory Capital00 00--
Two Sigma00 00--

Institutional-manager reports, all 178 managers: 269,106 for, 2,268 abstained, 71,857,527 1 year, 171,591 3 year, 2,140 unknown. Showing the 25 largest; every one is in the interactive database (link above).

The ratification of the selection, by the Audit Committee of the Board of Directors of the Company, of…

Calculated outcomeAUDIT-RELATEDPassed (calculated)

Combines 6 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 70,923,175AGAINST: 6,295

Prior year: 99.9% for (June 6, 2023 meeting) ▲ 0.1 pts

Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024; and

IDEAYA BIOSCIENCES INC.’s own tally for this item (“2. The ratification of the selection, by the Audit Committee of the Board of Directors of the Company, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending”): 70,923,175 for, 6,295 against, per its Form 8-K filed May 31, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 31,790,593 for, 6,828 abstained.

FOR
FOR: 31,790,593ABSTAIN: 6,828
Largest asset managers voting on “To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers” at IDEAYA BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity7,419,0050 00For
Federated Hermes4,855,7900 00For
Vanguard4,019,9690 00For
T. Rowe Price3,122,9830 00For
JANUS INVESTMENT FUND2,071,4380 00For
Capital Group1,976,8700 00For
BlackRock1,973,7630 00For
State Street1,651,7010 00For
Dimensional1,095,6790 00For
Charles Schwab570,3070 00For
MUTUAL FUND SERIES TRUST335,0000 00For
TIAA293,7650 00For
Victory Capital236,2790 00For
Prudential/PGIM203,1850 00For
Equitable191,3070 00For
Invesco175,5330 00For
Columbia Threadneedle120,3540 00For
Bridge Builder Trust107,9050 00For
New York Life104,7830 00For
Direxion Shares ETF Trust98,7850 00For
Lincoln Financial82,2590 00For
First Trust80,5100 00For
Northern Trust68,6340 00For
Goldman Sachs65,9990 00For
Nushares ETF Trust63,9990 00For

Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).

Largest IDEAYA BIOSCIENCES INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 74,764,628 shares outstanding at the time of that meeting.

Fund voting reports: top IDEAYA BIOSCIENCES INC. shareholders by shares voted on “To approve, on a non-binding, advisory basis, the compensation of the Company's named executive…”, 2023-2024
#Asset manager % of shares outstanding
1Fidelity 9.92%
2Federated Hermes 6.49%
3Vanguard 5.38%
4T. Rowe Price 4.18%
5JANUS INVESTMENT FUND 2.77%
6Capital Group 2.64%
7BlackRock 2.64%
8State Street 2.21%
9Dimensional 1.47%
10Charles Schwab 0.76%
Institutional-manager reports: top IDEAYA BIOSCIENCES INC. shareholders by shares voted on “To approve, on a non-binding, advisory basis, the compensation of the Company's named executive…”, 2023-2024
#Asset manager % of shares outstanding
1New York Life 25.41%
2Fidelity 13.65%
3Federated Hermes 6.50%
4T. Rowe Price 5.23%
5Janus Henderson 5.05%
6State Street 3.91%
7DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3.34%
8ADAGE CAPITAL PARTNERS GP, L.L.C. 3.23%
9Boxer Capital, LLC 2.95%
10Capital Research Global Investors 2.64%

Reported IDEAYA BIOSCIENCES INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

IDEAYA BIOSCIENCES INC. holdings and ownership disclosed for the 2023-2024 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
FMR (Fidelity)13,146,545 17.58%Form 13F, quarter ended March 31, 2024
FMR LLC8,160,206 10.91%Proxy statement (DEF 14A), proxy filed April 19, 2024
BlackRock8,127,226 10.87%Form 13F, quarter ended March 31, 2024
Vanguard Group4,922,208 6.58%Form 13F, quarter ended March 31, 2024
T. Rowe Price4,052,500 5.42%Form 13F, quarter ended March 31, 2024
Federated Hermes, Inc.3,883,775 5.19%Proxy statement (DEF 14A), proxy filed April 19, 2024
State Street3,163,954 4.23%Form 13F, quarter ended March 31, 2024
Morgan Stanley1,580,353 2.11%Form 13F, quarter ended March 31, 2024
Canaan X L.P.1,570,820 2.10%Schedule 13G, filed February 1, 2024
Geode Capital1,565,715 2.09%Form 13F, quarter ended March 31, 2024

Percentages above are of 74,764,628 shares outstanding, as reported by IDEAYA BIOSCIENCES INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At IDEAYA BIOSCIENCES INC.'s shareholder meeting held May 31, 2024, in the 2023-2024 proxy season, 239 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 1,798 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a non-binding, advisory basis, the compensation of the Company's named executive… — FOR was 93% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: IDEAYA BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 31, 2024.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from IDEAYA BIOSCIENCES INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

IDEAYA BIOSCIENCES INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Cite this page

Proxy Votes Now, “IDEAYA BIOSCIENCES (IDYA) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/ideaya-biosciences-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.